Bill > HB2057

This bill addresses regulations around 340B drugs, which are prescription drugs purchased at a discount by certain healthcare providers under a federal program. The legislation prohibits insurers and pharmacy benefit managers (PBMs) from requiring claims for prescription drugs to include a modifier or indicator identifying the drug as a 340B drug, with two specific exceptions: when the claim is for payment by a state medical assistance program or when the modifier is legally required to prevent duplicate discounts or rebates. The bill amends existing Oregon Revised Statutes to clarify that PBMs cannot reimburse 340B pharmacies differently based on their status and cannot impose additional requirements on these pharmacies. By preventing mandatory labeling of 340B drugs, the legislation aims to reduce administrative burdens on pharmacies and ensure consistent reimbursement practices. The bill will take effect 91 days after the adjournment of the 2025 regular legislative session, providing time for healthcare providers, insurers, and PBMs to adjust to the new requirements.

Health and Social Services

https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB2057